This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Elaine M. Smith, PhD, MPH; Shirley S. N. Pignatari, MD; Steven D. Gray, MD; Thomas H. Haugen, MD, PhD; Lubomir P. Turek, MD

Arch Otolaryngol Head Neck Surg. 1993;119(5):554-557.

Abstract
• We examined human papillomavirus (HPV) infection in biopsy specimens and cellular scrapes that were taken from respiratory papillomas and six nondiseased sites from the respiratory tract of seven patients. Human papillomavirus was detected by polymerase chain reaction amplification, followed by DNA hybridization with probes for specific HPV types. All papillomas (100.0%, n=5) were positive only for HPV type 6 or 11. In the nondiseased site specimens, 61.3% (19/31) of the specimens were positive, again only for HPV type 6 or 11. Among the nondiseased site specimens from the cervical trachea, intrathoracic trachea, and bronchus, 80% to 100% were HPV positive compared with only 25% to 50% of HPV infection detected in the nasopharynx, posterior tonsillar pillar, and aryepiglottic fold. These results support the tenet that HPV infection is present in clinically normal respiratory tract tissue and that the reservoir site of reinfection is more commonly in the lower airway. However, patients with upper-airway involvement were more likely to be diagnosed as having severe disease.

(Arch Otolaryngol Head Neck Surg. 1993;119:554-557)

Author Affiliations
From the Departments of Preventive Medicine (Dr Smith) and Pathology (Drs Haugen and Turek), College of Medicine, University of Iowa, Iowa City; the Disciplina de Otorrinolaringologia, Departamento de Oftalmo-Otorrinolaringologia, da Escola Paulista de Medicina, São Paulo, Brazil (Dr Pignatari); the Division of Otolaryngology, Department of Surgery, College of Medicine, University of Utah, Salt Lake City (Dr Gray); and the Department of Pathology, Veterans Administration Medical Center, Iowa City, Iowa (Drs Haugen and Turek).

Footnotes
Accepted for publication July 16, 1992.

Presented at the International Human Papillomavirus Workshop, Seattle, Wash, July 22, 1991.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Presence of DNA of Human Papillomavirus 16 but No Other Types in Tumor-Free Tonsillar Tissue
Chen et al.
J. Clin. Microbiol. 2005;43:1408-1410.
ABSTRACT | FULL TEXT  

HPV infections and tonsillar carcinoma
Syrjanen
J. Clin. Pathol. 2004;57:449-455.
ABSTRACT | FULL TEXT  

Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism
Lee et al.
Proc. Natl. Acad. Sci. USA 2004;101:2094-2099.
ABSTRACT | FULL TEXT  

Molecular Identification of 7 Human Papillomavirus Types in Recurrent Respiratory Papillomatosis
Penaloza-Plascencia et al.
Arch Otolaryngol Head Neck Surg 2000;126:1119-1123.
ABSTRACT | FULL TEXT  

Pathological Case of the Month
Ray et al.
Arch Pediatr Adolesc Med 1998;152:407-408.
FULL TEXT  

Late Recurrences of Laryngeal Papillomatosis
Erisen et al.
Arch Otolaryngol Head Neck Surg 1996;122:942-944.
ABSTRACT